Vanda Pharmaceuticals
VNDA
VNDA
187 hedge funds and large institutions have $819M invested in Vanda Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 72 increasing their positions, 63 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
187
Holders Change
+11
Holders Change %
+6.25%
% of All Funds
3.29%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
30
Increased
72
Reduced
63
Closed
17
Calls
$1.84M
Puts
$1.82M
Net Calls
+$25K
Net Calls Change
+$1.81M
Top Buyers
| 1 |
EIP
Epoch Investment Partners
New York
|
$17.4M |
| 2 |
LSV Asset Management
Chicago,
Illinois
|
$19.8M |
| 3 |
D.E. Shaw & Co
New York
|
$11.3M |
| 4 |
BlackRock
New York
|
$151M |
| 5 |
Citigroup
New York
|
$2.9M |
